Skip to main content
Log in

Merkel Cell Carcinoma of Skin

Diagnosis and Management Strategies

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Merkel cell carcinoma (MCC) of the skin is a rare form of cutaneous malignancy of neuroendocrine origin with a propensity to affect predominately elderly patients in sun-exposed areas. The tumour has an extremely aggressive growth pattern with the potential to seed into the dermal lymphatics at an early stage as well as spread to nodes and distant sites. Successful outcomes can be achieved with early diagnosis and a multidisciplinary approach to management. Patients with MCC should be carefully staged to exclude distant metastatic disease. Treatment should be approached with both the primary site and the lymph nodes in mind. The primary site should be excised with clear margins, followed by postoperative radiotherapy to the primary site and affected nodes. Addition of chemotherapy to patients perceived to be at high-risk of distant recurrence (e.g. those with involved nodes) has been considered, but evidence supporting this approach is relatively scant. This treatment strategy needs to be approached with caution in the elderly because of the risk of myelosuppression. An aggressive treatment approach is warranted at the first attempt to treat MCC as treatment for recurrent disease is less likely to be successful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Table I
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Halata Z, Grim M, Baumann KI. Friedrich Sigmund Merkel and his ‘Merkel cell’ morphology, development and physiology: review and new results. Anat Rec 2003; 271: 225–39

    Article  Google Scholar 

  2. Szeder V, Grim M, Halata Z, et al. Neural crest origin of mammalian Merkel cells. Dev Biol 2003; 253: 258–63

    Article  PubMed  CAS  Google Scholar 

  3. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105: 107–10

    Article  PubMed  CAS  Google Scholar 

  4. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978; 42: 2311–21

    Article  PubMed  CAS  Google Scholar 

  5. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8(2): 153–8

    PubMed  CAS  Google Scholar 

  6. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002; 20(2): 588–98

    Article  PubMed  Google Scholar 

  7. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 1995; 21: 669–83

    Article  PubMed  CAS  Google Scholar 

  8. Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002; 34(5): 1780–1

    Article  PubMed  CAS  Google Scholar 

  9. Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more commonly than previously recognised in a temperate climate. Transplantation 2004; 77(4): 574–9

    Article  PubMed  CAS  Google Scholar 

  10. Engels EA, Frisch M, Goedart JJ, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359(9305): 497–8

    Article  PubMed  Google Scholar 

  11. Sais G, Admella C, Soler T. Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon? J Eur Acad Dermatol Venereol 2002; 16(1): 82–3

    Article  PubMed  CAS  Google Scholar 

  12. Raaf JH, Urmacher C, Knapper WK, et al. Trabecular (Merkel cell) carcinoma of the skin: treatment of primary, recurrent and metastatic disease. Cancer 1986; 57: 178–82

    Article  PubMed  CAS  Google Scholar 

  13. Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999; 85(12): 2589–95

    Article  PubMed  CAS  Google Scholar 

  14. Pillotti S, Rilke F, Bartoli C, et al. Clinicopathological correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol 1988; 6: 1863–73

    Google Scholar 

  15. Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected in monoclonal antibodies. Am J Pathol 1992; 140(2): 427–47

    PubMed  CAS  Google Scholar 

  16. Byrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor-1 (TTF-1) in small cell carcinoma and Merkel cell carcinoma. Hum Pathol 2000; 31(1): 58–62

    Article  PubMed  CAS  Google Scholar 

  17. Su LD, Fullen DR, Lowe L, et al. CD 117 (KIT receptor) expression in Merkel cell carcinoma [abstract]. Am J Dermatopathol 2002; 24(4): 289–93

    Article  PubMed  Google Scholar 

  18. Van Gele M, Leonard JH, Van Roy N, et al. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal arrangements in Merkel cell carcinoma. Int J Cancer 2002; 101(2): 137–45

    Article  PubMed  Google Scholar 

  19. Harnett PR, Kearsley JH, Hayward NK, et al. Loss of allelic heterozygosity on distal chromosome 1p in Merkel cell carcinoma: a marker of neural crest origins. Cancer Genet Cytogenet 1991; 54: 109–13

    Article  PubMed  CAS  Google Scholar 

  20. Leonard JH, Cook AL, Nancarrow D, et al. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma. Cancer Detect Prev 2000; 24: 620–7

    PubMed  CAS  Google Scholar 

  21. Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000; 82(4): 823–6

    Article  PubMed  Google Scholar 

  22. Vortmeyer AO, Merino MJ, Boni R, et al. Genetic changes associated with Merkel cell carcinoma. Am J Clin Pathol 1998; 109(5): 565–70

    PubMed  CAS  Google Scholar 

  23. Larsimont D, Verhest A. Chromosome 6 trisomy as sole anomaly in a primary Merkel cell carcinoma. Virchows Arch 1996; 428(4–5): 305–9

    PubMed  CAS  Google Scholar 

  24. Leonard JH, Leonard P, Kearsley JH. Chromosomes 1, 11 and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet 1993; 67(1): 65–70

    Article  PubMed  CAS  Google Scholar 

  25. Nguyen BD, McCullough AE. Imaging of Merkel cell carcinoma. Radiographics 2002; 22(2): 367–76

    PubMed  Google Scholar 

  26. Nguyen BD. Positron emission tomographic imaging of Merkel cell carcinoma. Clin Nucl Med 2002; 27(12): 922–3

    Article  PubMed  Google Scholar 

  27. Kwekkeboom DJ, Hoff AM, Lamberts SW, et al. Somatostatin analogue scintigraphy: a simple and sensitive method for the in vivo visualisation of Merkel cell tumours and their metastases. Arch Dermatol 1992; 128: 818–21

    Article  PubMed  CAS  Google Scholar 

  28. Durani BK, Klein A, Henze M, et al. Somatostatin analogue scintigraphy in Merkel tumours. Br J Dermatol 2003; 148(6): 1135–40

    Article  PubMed  CAS  Google Scholar 

  29. Guitera-Rovel P, Lumbroso J, Gautier-Gougis MS, et al. Indium-111 octreotide scintigraphy of Merkel cell carcinoma and their metastases. Ann Oncol 2001; 12(6): 807–11

    Article  PubMed  CAS  Google Scholar 

  30. Wong CO, Pham AN, Dworkin HJ. F-18 FDG accumulation in an Octreotide Negative Merkel Cell Tumour. Clin Positron Imaging 2000; 3(2): 71–3

    Article  PubMed  Google Scholar 

  31. Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine and neural crest tumours. Clin Nucl Med 2004; 29(2): 86–9

    Article  PubMed  Google Scholar 

  32. Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma: prognosis and management. Arch Surg 1991; 126: 1514–9

    Article  PubMed  CAS  Google Scholar 

  33. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of post operative radiotherapy in the treatment of Merkel cell carcinoma. Int J Radiation Oncol Biol Phys 1995; 31: 325–31

    Article  CAS  Google Scholar 

  34. Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997; 80: 881–5

    Article  PubMed  CAS  Google Scholar 

  35. Morrison WH, Peters LJ, Silva EG, et al. The essential role of radiation therapy is securing locoregional control of Merkel cell carcinoma. Int J Radiation Oncol Biol Phys 1990; 19: 583–91

    Article  CAS  Google Scholar 

  36. Poulsen M, Rischin D, Walpole E, et al. High risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study TROG 96:07. J Clin Oncol 2003; 21(23): 4371–6

    Article  PubMed  CAS  Google Scholar 

  37. Koljonen V, Bohling T, Granhroth G, et al. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 2003; 29(7): 697–10

    Article  Google Scholar 

  38. Boyle F, Pendlebury S, Bell D. Further insights in to the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiation Oncol Biol Phys 1995; 31: 315–23

    Article  CAS  Google Scholar 

  39. Eich HT, Eich D, Staar S, et al. Role of postoperative radiotherapy in the management of Merkel cell. Am J Clin Oncol 2002; 25(1): 50–6

    Article  PubMed  Google Scholar 

  40. Coit DG. Merkel cell carcinoma. Ann Surg Oncol 2001; 8 (9 Suppl.): 99s–102s

    PubMed  CAS  Google Scholar 

  41. Leonard JH, Cook AL, Van Gele M, et al. Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma. Int J Cancer 2002; 101: 103–10

    Article  PubMed  CAS  Google Scholar 

  42. Ratner D, Nelson BR, Brown MD, et al. Merkel cell carcinoma. J Am Acad Derm 1993; 29: 143–56

    Article  PubMed  CAS  Google Scholar 

  43. Al Ghazal SK, Arora DS, Simpson RH, et al. Merkel cell carcinoma of the skin. Br J Plast Surg 1996; 49(7): 491–6

    Article  PubMed  CAS  Google Scholar 

  44. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and. Arch Otolaryngol Head Neck Surg 2001; 127(2): 149–54

    PubMed  CAS  Google Scholar 

  45. Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999; 229(1): 97–105

    Article  PubMed  CAS  Google Scholar 

  46. Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134(4): 388–92

    Article  PubMed  CAS  Google Scholar 

  47. Ashby M, Jones DH, Tasker AD, et al. Primary cutaneous neuroendocrine (Merkel cell or trabecular carcinoma) tumour of the skin: a radiosensitive tumour. Clin Radiol 1989; 40: 85–7

    Article  PubMed  CAS  Google Scholar 

  48. Roenigk RK, Goltz RW. Merkel cell carcinoma: a problem with micrographically controlled surgery. J Dermatol Surg Oncol 1986; 12: 332–6

    PubMed  CAS  Google Scholar 

  49. Rubsamen PE, Tanenbaum M, Grove AS, et al. Merkel cell carcinoma of the eyelid and periorbital tissues. Am J Ophthalmol 1992; 113: 674–80

    PubMed  CAS  Google Scholar 

  50. Boyer JD, Ziltelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated. J Am Acad Derm 2002; 47(6): 885–92

    Article  PubMed  Google Scholar 

  51. Brissett AE, Olsen KD, Kasperbauer JL, et al. Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck 2002; 24(11): 982–8

    Article  PubMed  Google Scholar 

  52. Victor NS, Morton B, Smith JW. Merkel cell carcinoma: is prophylactic lymph node dissection indicated? Am Surg 1996; 62: 879–82

    PubMed  CAS  Google Scholar 

  53. Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999; 86(4): 518–21

    Article  PubMed  CAS  Google Scholar 

  54. Rodrigues LK, Leong SP, Kashani-Sabet M, et al. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Derm 2001; 45(2): 303–8

    Article  PubMed  CAS  Google Scholar 

  55. Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: 5 reports using sentinel node biopsy and review of 110 cases. Plast Reconstr Surg 2002; 110(5): 1259–65

    Article  PubMed  Google Scholar 

  56. Wasserberg N, Schachter J, Fenig E, et al. Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 2000; 26(2): 138–41

    Article  PubMed  CAS  Google Scholar 

  57. Pacella J, Ashby M, Ainslie J, et al. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumours: experience of the Peter MacCallum Cancer Institute (Melbourne Australia). Int J Radiation Oncol Biol Phys 1988; 14: 1077–84

    Article  CAS  Google Scholar 

  58. Bourne RG, O’Rourke MG. Management of Merkel cell tumour. Aust N Z J Surg 1988; 58: 971–4

    Article  PubMed  CAS  Google Scholar 

  59. Leonard JH, Ramsay JR, Kearsley JH, et al. Radiation sensitivity of Merkel cell carcinoma cell lines. Int J Radiat Oncol Biol Phys 1995; 32: 1401–7

    Article  PubMed  CAS  Google Scholar 

  60. Tennvall J, Bjorklund A, Johansson L, et al. Merkel cell carcinoma: management of primary, recurrent and metastatic disease: a clinicopathological study of 17 patients. Eur J Surg Oncol 1989; 15: 1–9

    PubMed  CAS  Google Scholar 

  61. Marks ME, Kim RY, Salter MM. Radiotherapy as an adjunct in management of Merkel cell carcinoma. Cancer 1990; 65: 60–4

    Article  PubMed  CAS  Google Scholar 

  62. Goepfert H, Remmler D, Silva E, et al. Merkel cell carcinoma (endocrine carcinoma of skin) of the head and neck. Arch Otolaryngol 1984; 110: 707–12

    Article  PubMed  CAS  Google Scholar 

  63. Kokoska ER, Kokoska MS, Collins BT, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997; 174(6): 688–93

    Article  PubMed  CAS  Google Scholar 

  64. Herbst A, Haynes HA, Nghiem P. The standard of care for Merkel cell carcinoma should include adjuvant radiation and lymph node surgery. J Am Acad Derm 2002; 46(4): 640–2

    Article  PubMed  Google Scholar 

  65. Medina Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and review of 1024 cases. Ann Surg Oncol 2001; 8(3): 204–8

    Article  PubMed  CAS  Google Scholar 

  66. Mortier L, Mirabel X, Fournier C, et al. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 2003; 139(12): 1587–90

    Article  PubMed  Google Scholar 

  67. Shaw JH, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991; 78: 138–42

    Article  PubMed  CAS  Google Scholar 

  68. Suntharalingam M, Rudoltz MS, Mendenhall WM, et al. Radiotherapy for Merkel cell carcinoma of the skin of the head and neck. Head and Neck 1995; 17: 96–101

    Article  PubMed  CAS  Google Scholar 

  69. Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroen-docrine/Merkel cell carcinoma of the skin and review of 204 cases. J Clin Oncol 2000; 18: 2493–9

    PubMed  CAS  Google Scholar 

  70. Kearsley JH, Hurst T, Khoo SK. Chemosensitivity testing of primary cultures of Merkel cell cancer. Anticancer Drugs 1993; 4: 571–5

    Article  PubMed  CAS  Google Scholar 

  71. Fenig E, Brenner B, Njuguna E, et al. Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide. Am J Clin Oncol 2000; 23(1): 65–7

    Article  PubMed  CAS  Google Scholar 

  72. Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996; 14(3): 821–8

    PubMed  CAS  Google Scholar 

  73. Davis MP, Miller EM, Rau RC, et al. The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma. J Dermatol Surg Oncol 1990; 16: 276–8

    PubMed  CAS  Google Scholar 

  74. Poulsen M, Rischin D, Walpole E, et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study. Int J Rad Oncology Biol Phys 2001; 51(1): 156–63

    Article  CAS  Google Scholar 

  75. Olieman AF, Lienard D, Eggermont AM, et al. Hyperthermic isolated limb perfusion with tumour necrosis factor, interferon gamma, and melphalan for locally advanced non melanomatous skin tumours of the extremities: a multicentre study. Arch Surg 1999; 134: 303–7

    Article  PubMed  CAS  Google Scholar 

  76. Hata Y, Matsuka K, Ito O, et al. Two cases of Merkel cell carcinoma cured by intratumour injection of natural human tumour necrosis factor. Plast Reconstr Surg 1997; 99: 547–53

    Article  PubMed  CAS  Google Scholar 

  77. Bajetta E, Rimassa L, Carnaghi C, et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of neuroendocrine tumours. Cancer 1998; 1998: 372–8

    Article  Google Scholar 

  78. Zilembo N, Buzzoni R, Bajetta E, et al. Salvage treatment after r-interferon alpha-2a in advance neuroendocrine carcinoma. Acta Oncol 1993; 32: 245–50

    Article  PubMed  CAS  Google Scholar 

  79. di-Bartolomeo M, Bajetta E, Buzzoni R, et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumours: a study by the Italian Trials in Medical Oncology Group. Cancer 1996; 77: 402–8

    Article  PubMed  CAS  Google Scholar 

  80. Poulsen M, Harvey J. Is there a diminishing role for surgery in Merkel cell carcinoma of the skin? A review of the current management. ANZ J Surg 2002; 72(2): 142–6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

There has been no assistance in the preparation of the manuscript from outside bodies and there are no conflicts of interest in any of the statements made or claimed in this paper. The support of Mayne Pharma for a study grant in 2004 to carry out a pilot study of synchronous weekly carboplatin and radiation in Merkel cell carcinoma of the skin is acknowledged.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poulsen, M. Merkel Cell Carcinoma of Skin. Drugs Aging 22, 219–229 (2005). https://doi.org/10.2165/00002512-200522030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200522030-00004

Keywords

Navigation